(2R)-3-(2-Chloro-4-nitro-1H-imidazol-1-yl)-2-methyl-1,2-propanediol
(2R)-3-(2-Chloro-4-nitro-1H-imidazol-1-yl)-2-methyl-1,2-propanediol is an intermediate in the synthesis of Delamanid (D230660), a novel anti-tuberculosis medication that inhibits mycolic acid synthesis and shows potent in-vitro and in-vivo activity against drug-resistant strains of Mycobacterium tuberculosis.
| Catalog Number | BB062336 |
| Alternative Name(s) | (R)-3-(2-Chloro-4-nitro-1H-imidazol-1-yl)-2-methylpropane-1,2-diol; (R)-2-chloro-1-(2,3-dihydroxy-2-methylpropyl)-4-nitroimidazole |
| Molecular Formula | C7H10ClN3O4 |
| CAS# | 681490-91-5 |
| Inchi | InChI=1S/C7H10ClN3O4/c1-7(13,4-12)3-10-2-5(11(14)15)9-6(10)8/h2,12-13H,3-4H2,1H3/t7-/m1/s1 |
| Inchi Key | UEYAJHCNNXRAIQ-SSDOTTSWSA-N |
| Size | Please inquire |
| Supplier Page | https://buildingblock.bocsci.com/product/2r-3-2-chloro-4-nitro-1h-imidazol-1-yl-2-methyl-cas-681490-91-5-395241.html |
